To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen
Public ClinicalTrials.gov record NCT00715078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Single Blind Study in Men With Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
Study identification
- NCT ID
- NCT00715078
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Dendreon
- Industry
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
- sipuleucel-T Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2008
- Primary completion
- Mar 31, 2012
- Completion
- Apr 30, 2015
- Last update posted
- May 22, 2017
2008 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Moores Cancer Center | La Jolla | California | 92093-0820 | — |
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Providence Medical Center | Portland | Oregon | 97213 | — |
| Kaiser Permanente | Portland | Oregon | 97227 | — |
| Northwest Cancer Specialists | Portland | Oregon | 97227 | — |
| Urology of Virginia, Sentara Medical Group | Norfolk | Virginia | 23503 | — |
| Virginia Mason Medical Center Urology and Renal Transplantation | Seattle | Washington | 98101 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98102 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00715078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2017 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00715078 live on ClinicalTrials.gov.